| Trial ID: | L2889 |
| Source ID: | NCT02636192
|
| Associated Drug: |
No Intervention
|
| Title: |
Study on Incidence of Diabetic Ketoacidosis Among Participants With Type 2 Diabetes Mellitus Treated With Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors or Other Antihyperglycemic Agents
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: No Intervention
|
| Outcome Measures: |
Primary: Number of Participants with a recorded diagnosis of Diabetic Ketoacidosis (DKA), Day 1 |
|
| Sponsor/Collaborators: |
Sponsor: Janssen Research & Development, LLC
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
2e+05
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2015-07-31
|
| Completion Date: |
2017-04-07
|
| Results First Posted: |
|
| Last Update Posted: |
2017-04-13
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT02636192
|
